A Pivotal Step in Advancing PerDeCT
Fallouh Healthcare was awarded a £500,000 grant from Innovate UK, the UK’s national innovation agency, to develop— PerDeCT,
This award marked a transformative moment in our journey, helping us move from concept to prototype and proving that real-world surgical challenges can inspire real-world solutions.
Built Through Collaboration
Delivered in partnership with:
- University Hospitals Birmingham NHS Foundation Trust
- The University of Sheffield
The project combined clinical insight and academic research to build a solution that reflects the real needs of frontline healthcare teams.
Why It Matters: Reimagining Cardiac Tamponade Diagnosis
Cardiac tamponade is a life-threatening complication that’s difficult to detect early with conventional tools. PerDeCT changes the equation — offering a quick, simple, and reliable way to identify fluid build-up around the heart before symptoms become critical.
PerDeCT is:
- Non-invasive and easy to use at the bedside
- Designed for high-pressure environments like ICU and post-op wards
- Built with input from clinicians who understand what’s at stake
What the Grant Enabled
- Prototype Development
Built and refined our first-generation PerDeCT device, aligned to real clinical performance needs.
- Human-Centred Design
Collaborated with surgeons and ICU clinicians to ensure usability in demanding surgical environments.
- Usability Testing at MD-TEC
Conducted hands-on evaluations at Queen Elizabeth Hospital (Medical Device Testing & Evaluation Centre), one of the UK’s top medtech testing hubs.
- Regulatory Roadmap
Laid the foundations for CE marking and future clinical trials by initiating a regulatory strategy.
Outcomes and Impact
This Innovate UK project was more than product development — it validated our clinical relevance, engaged key NHS stakeholders, and paved the way for future investment and trials. It directly contributed to our success in securing follow-on funding, including our Eurostars award for preclinical studies.
This grant affirmed our belief: ”when innovation starts with the clinician, the result is a device the whole system can trust”. CEO Hazem Fallouh